Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hooper

Showing results (451-460 of 470) with videos related to

Pageof 47
Sort By:
Anesthesia and Analgesia|December 21, 2013
Consensus guidelines for the management of postoperative nausea and vomitingTong J Gan, Pierre Diemunsch, Ashraf S Habib, et al.
Journal of Occupational and Environmental Medicine|January 25, 2020
Non-Invasive and Minimally Invasive Management of Low Back DisordersKurt T Hegmann, Russell Travis, Gunnar B J Andersson, et al.
JCI Insight|October 15, 2020
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.
British Journal of Cancer|April 7, 2026
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancerZhen Zeng, Anastasia Gandini, Rituparna Bhatt, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 20, 2023
UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancerBrittney S Harrington, Rahul Kamdar, Franklin Ning, et al.
JCI Insight|November 16, 2018
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.
Molecular Pharmaceutics|August 27, 2021
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian CancerYaowu He, Tashbib Khan, Thomas Kryza, et al.
Cancers|September 28, 2021
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung CancerKatherine B Sahin, Esha T Shah, Genevieve P Ferguson, et al.
Theranostics|February 28, 2020
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancerBrittney S Harrington, Yaowu He, Tashbib Khan, et al.
Theranostics|April 1, 2020
Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinomaThomas Kryza, Tashbib Khan, Simon Puttick, et al.
Pageof 47

Showing results (451-460 of 470) with videos related to

Sort By:
Pageof 47
Anesthesia and Analgesia|December 21, 2013
Consensus guidelines for the management of postoperative nausea and vomitingTong J Gan, Pierre Diemunsch, Ashraf S Habib, et al.
Journal of Occupational and Environmental Medicine|January 25, 2020
Non-Invasive and Minimally Invasive Management of Low Back DisordersKurt T Hegmann, Russell Travis, Gunnar B J Andersson, et al.
JCI Insight|October 15, 2020
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.
British Journal of Cancer|April 7, 2026
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancerZhen Zeng, Anastasia Gandini, Rituparna Bhatt, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 20, 2023
UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancerBrittney S Harrington, Rahul Kamdar, Franklin Ning, et al.
JCI Insight|November 16, 2018
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.
Molecular Pharmaceutics|August 27, 2021
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian CancerYaowu He, Tashbib Khan, Thomas Kryza, et al.
Cancers|September 28, 2021
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung CancerKatherine B Sahin, Esha T Shah, Genevieve P Ferguson, et al.
Theranostics|February 28, 2020
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancerBrittney S Harrington, Yaowu He, Tashbib Khan, et al.
Theranostics|April 1, 2020
Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinomaThomas Kryza, Tashbib Khan, Simon Puttick, et al.
Pageof 47